Granisetron Transdermal Patch: Clinical Trials

2 trials of Granisetron Transdermal Patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow Granisetron Transdermal Patch: new trials by email Literature Review of Granisetron Transdermal Patch trials Research Report on Granisetron Transdermal Patch

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Sancuso - Part 1, Sancuso - Part 2 - Healthy Volunteers
Phase 1CompletedKyowa Kirin, Inc.1342021-07-062024-06-14
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
granisetron transdermal system, fosaprepitant dimeglumine, laboratory biomarker analysis - Breast Cancer, Nausea
Phase 1TerminatedUniversity of Southern California292012-09-042017-11-17

Conditions studied

Nausea (2)  ·  Breast Neoplasms (1)  ·  Vomiting (1)

Sponsors

Kyowa Kirin, Inc. (1)  ·  University of Southern California (1)

Countries

United States (2)

Top investigators

Agustin Garcia (1)